Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation molecule (CD)28 but not CD3 receptors on murine thymocytes and spleen cells

British Journal of Nutrition

Volumn 90, Issue 1, 2003, Pages 179-189

  Kuvibidila, Solo R ^a   Porretta, Connie ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD3 and CD28 receptors; Deferoxamine; Iron deficiency; Lymphocyte proliferation; Thymus

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CONCANAVALIN A; DEFEROXAMINE; FLUORESCEIN ISOTHIOCYANATE; HEMOGLOBIN; IRON; LYMPHOCYTE ANTIGEN RECEPTOR; PHYCOERYTHRIN; IRON CHELATING AGENT; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE CLUSTER; HEMOGLOBIN DETERMINATION; IN VITRO STUDY; IRON CHELATION; IRON DEFICIENCY; IRON DEPLETION; IRON INTAKE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; SPLENOMEGALY; T LYMPHOCYTE; THYMOCYTE; THYMUS ATROPHY; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; IRON DEFICIENCY ANEMIA; LIVER; LYMPHOCYTE ACTIVATION; METABOLISM; NUTRITIONAL STATUS; SPLEEN;

ANIMALIA; MURINAE;

ANEMIA, IRON-DEFICIENCY; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; CELLS, CULTURED; CONCANAVALIN A; FEMALE; HEMOGLOBINS; IRON; IRON CHELATING AGENTS; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; MITOGENS; NUTRITIONAL STATUS; SPLEEN; T-LYMPHOCYTES;

EID: 0042871288     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2003864     Document Type: Article

References (31)

1. Abbas AK, Lichtman AH & Pober JS (1997) T lymphocyte antigen recognition and activation. In Cellular and Molecular Immunology, pp. 138-170 [AK Abbas, AH Lichtman and JS Pober, editors]. Philadelphia, PA: WB Saunders Company.
2. Chandra RK & Saraya AK (1975) Immunocompetence associated with iron deficiency. J Pediatr 86, 899-902.
3. Dhur A, Galan P, Preziosi P & Hercberg S (1991) Lymphocyte subpopulations in the thymus, lymph nodes, and spleen of iron-deficient and rehabilitated mice. J Nutr 121, 1418-1424.
4. Furukawa T, Naitoh Y, Kohno H, Tokinaga R & Taketani S (1992) Iron deprivation decreases ribonucleotide reductase and DNA synthesis. Life Sci 50, 2059-2065.
5. Galan P, Thibault H, Preziosi P & Hercberg S (1992) Interleukin-2 production in iron-deficient children. Biol Trace Elem Res 32, 421-426.
6. Gross JA, Callas E & Allison JP (1992) Identification and distribution of the co-stimulatory receptor CD28 in the mouse. J Immunol 149, 380-388.
7. Haq RU, Wereley JP & Chitambar C (1995) Induction of apoptosis by iron deprivation in human leukemic CCCRI-CEM cells. Exp Hematol 23, 428-432.
8. Harding FA, McArthur JG, Gross JA, Raulet DH & Allison JP (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609.
9. Hathcock KS, Laslo G, Pucillo C, Linsley P & Hodes RJ (1994) Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: Expression and function. J Exp Med 180, 631-640.
10. Havran WL, Poenie M, Kimura J, et al. (1987) Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes. Nature 330, 170-173.
11. Hileti D, Panayiotidis P & Hoffbrand AV (1995) Iron chelators induce apoptosis in proliferating cells. Br J Haematol 89, 181-187.
12. June CH, Bluestone JA, Nadler LM & Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15, 321-331.
13. June CH, Ledbetter JA, Linsley PS & Thompson CB (1990) Role of the CD28 receptor in T-cell activation. Immunol Today 11, 211-216.
14. Kemahli AS, Babacan E & Cavdar AO (1988) Cell-mediated immune responses in children with iron deficiency and combined with iron and zinc deficiency. Research 8, 129-136.
15. Kuvibidila S, Dardenne M, Savino M & Lepol F (1990) Influence of iron deficiency anaemia on selected thymus functions in mice: Thymulin biological activity, T-cell subsets, and thymocyte proliferation. Am J Clin Nutr 51, 228-232.
16. Kuvibidila S, Nauss KM, Baliga BS & Suskind RM (1983) Impairment of blastogenic response of splenic lymphocytes from iron deficient mice: In vivo repletion. Am J Clin Nutr 37, 15-25.
17. Kuvividila S & Porretta C (2002) Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells. J Cell Biochem 86, 571-582.
18. Kuvibidila S & Sarpong D (1990) Mitogenic response of lymph nodes and spleen cells from mice with moderate and severe iron deficiency. Nutr Res 10, 195-210.
19. Kuvibidila SR, Baliga BS, Warrier RP & Suskind RM (1998) Iron deficiency reduces the hydrolysis of cell membrane phosphatidyl-inositol 4,5 bis-phosphate during splenic lymphocyte activation in C57BL/6 mice. J Nutr 128, 1077-1083.
20. Kuvibidila SR, Kitchens D & Baliga BS (1999) In vivo and in vitro iron-deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells. J Cell Biochem 74, 468-478.
21. Kuvibidila SR, Porretta C, Baliga BS & Leiva LE (2001) Reduced thymocyte proliferation but not increased apoptosis as a cause of thymus atrophy in iron-deficienct mice. Br J Nutr 86, 157-162.
22. Latunde-Dada GO & Young AP (1992) Iron deficiency and immune response. Scand J Immunol 11, 207-209.
23. Looker AC, Dallman PR, Carroll MD, Gunter EW & Johnson CL (1997) Prevalence of iron deficiency in the United States. JAMA 277, 973-976.
24. Munro HB (1993) Differences among group means: One way analysis of variance. In Statistical Methods for Health Care Research, 2nd ed., pp. 99-128 [HB Munro and EB Page, editors]. Philadelphia, PA: JB Lippincott Company.
25. Polson RJ, Jenkins R, Lombard M, et al. (1990) Mechanisms of inhibition of mononuclear cell activation by the iron-deficient desferrioxamine. Immunology, 71, 176-181.
26. Rodak BF (1992) Routine laboratory evaluation of erythrocytes. In Clinical Hematology, Principles, Procedures, Correlations, pp. 107-123 [CA Lotspeich-Steininger, EA Stiene-Martin and JA Koepke, editors]. Philadelphia, PA: J.B. Lippincott Company.
27. Santos M & De Sousa M (1994) In vitro modulation of T-cell surface molecules by iron. Cell Immunol 154, 498-506.
28. Shahinian T, Pfeffer K, Lee PK, et al. (1993) Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 261, 609-612.
29. Thompson CB, Lindsten T, Ledbetter JA, et al. (1989) CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA 86, 1333-1337.
30. Turka LA, Ledbetter JA, Lee K, June CH & Thompson CB (1990) CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J Immunol 144, 1646-1653.
31. Turka LA, Linsley PS, Paine R III, et al. (1991) Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes: Implications for thymus selection. J Immunol 146, 1428-1436.